Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism Interventions: Drug: Cinacalcet; Drug: Placebo Sponsor: Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2018 Category: Research Source Type: clinical trials
